$28.64+0.65|(+2.32%)
52W H: 93.6152W L: 21.35Beta: 0.50

About Liquidia Corp

Frequently Asked Questions

What is the 52-week range for LQDA?

The 52-week high is $93.61 and the 52-week low is $21.35.

What is the P/E ratio for LQDA?

The Price to Earnings (P/E) ratio is 18.50.

What is the dividend yield for LQDA?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is 149.64%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is 30.74%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 12.93.

Analyst Recommendation Trends

Wall Street analyst consensus for LQDA over the last few months:

2026-09-01
Buy: 6
S.Buy: 5
Hold: 4
Sell: 0
2026-08-01
Buy: 7
S.Buy: 5
Hold: 3
Sell: 0
2026-07-01
Buy: 7
S.Buy: 5
Hold: 2
Sell: 0
2026-06-01
Buy: 7
S.Buy: 6
Hold: 1
Sell: 0

Latest LQDA News

Stocktwits Wall Street Wrap: Analysts Turn Bullish On Sweetgreen, Target And Airbnb – Liquidia And FICO Face Downgrades

The changes reflect new views on restaurant demand, retail traffic, travel growth, drug risks and competition in financial data.

Yahoo10/2/2026

Wells Fargo Downgrades Liquidia to Equal-Weight, Lowers Price Target to $30

Wells Fargo analyst Benjamin Burnett downgrades Liquidia (NASDAQ:LQDA) from Overweight to Equal-Weight and lowers the price target from $108 to $30.

Benzinga10/2/2026

HC Wainwright & Co. Maintains Buy on Liquidia, Lowers Price Target to $58

HC Wainwright & Co. analyst Andrew S. Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $130 to $58.

Benzinga10/2/2026

United Therapeutics Just Sent Liquidia Stock Lower After Patent Battle

Liquidia stock crashes as United Therapeutics secures victory in Delaware District Court. Here’s why LQDA shares aren’t worth buying on the dip.

Yahoo10/1/2026

Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet

Check out the companies making headlines yesterday:

Yahoo10/1/2026

LQDA Stock On Track For Worst Week Ever As Analysts Say The Yutrepia Patent Loss Clouds Its Path

U.S. District Judge Richard G. Andrews of the District of Delaware found on Wednesday that Liquidia induces infringement of claims 1 and 14 of United Therapeutics’ U.S. Patent No. 11,826,327.

Yahoo10/1/2026

Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback

LQDA faces a major setback as a patent ruling threatens Yutrepia's PH-ILD indication and creates uncertainty around its commercial outlook.

Yahoo10/1/2026

Liquidia Stock Extends Slide Following US Court Ruling in Patent Dispute

Shares of Liquidia Corp (NASDAQ:LQDA) are sliding Thursday morning, extending a sell-off triggered by an adverse federal court patent ruling in its ongoing legal dispute with rival United Therapeutics. Here’s what investors need to know. Liquidia stock is feeling bearish pressure. Why is LQDA stock dropping? Federal District Court Patent Ruling The primary driver behind Thursday’s weakness is a ruling issued Wednesday by the U.S. District Court for the District of Delaware in ongoing Hatch-Waxma

Yahoo10/1/2026

UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%

United Therapeutics secures a key patent ruling against Liquidia, potentially limiting Yutrepia's PH-ILD use and reducing competition for its Tyvaso products.

Yahoo10/1/2026

United Therapeutics Won Its Patent War and Liquidia Collapsed

A single court ruling sent one pulmonary hypertension drugmaker soaring and left its rival fighting for survival, but the legal battle over Yutrepia's future is far from settled.

Yahoo10/1/2026

Liquidia Sinks Another 17% as BofA Cuts Target to $40 From $92 After Court Loss

Key TakeawaysLiquidia shares are down 14% after BofA cut its price target to $40 from $92, and BTIG and Raymond James both downgraded the stock. The drop follows Wednesday’s roughly 57% crash, after a Delaware court ruled that Yutrepia infringes two claims of a United Therapeutics patent.

Yahoo10/1/2026

Apple To $355? Here Are 10 Top Analyst Forecasts For Thursday

Analysts raised targets for HPE, Phillips 66, Micron and AEON; cut targets for Liquidia, Apple and Zions.

Benzinga10/1/2026

Exxon Mobil downgraded, BP upgraded: Wall Street's top analyst calls

Exxon Mobil downgraded, BP upgraded: Wall Street's top analyst calls

Yahoo10/1/2026

Raymond James Downgrades Liquidia to Outperform, Lowers Price Target to $53

Raymond James analyst Ryan Deschner downgrades Liquidia (NASDAQ:LQDA) from Strong Buy to Outperform and lowers the price target from $106 to $53.

Benzinga10/1/2026

This ExxonMobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded Liquidia, Sigma Lithium, ExxonMobil, Ormat Technologies and Ethos Technologies, with updated or reduced price targets.

Benzinga10/1/2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers DataMEDS AI (NASDAQ:MEDS) stock moved upwards by 39.4% to $4.42 during Thursday's pre-market session. The company's market cap stands at $10.1 million. Stablecoin Development (AMEX:SDEV) shares moved

Benzinga10/1/2026

Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

U.S. stock futures were mixed as Progress Software fell after results; Corteva, NFT, Vivakor and other stocks also dropped in premarket trading.

Benzinga10/1/2026

BTIG Downgrades Liquidia to Neutral

BTIG analyst Julian Harrison downgrades Liquidia (NASDAQ:LQDA) from Buy to Neutral.

Benzinga10/1/2026

Needham Maintains Buy on Liquidia, Lowers Price Target to $72

Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $110 to $72.

Benzinga10/1/2026

Liquidia Stock Crashed 57% in a Day After a Delaware Court Ruling. An Appeal Could Decide Whether Shares Rebound.

Why Liquidia Stock Crashed 57% on Wednesday’s Patent Ruling Against YutrepiaLiquidia (LQDA:NASDAQ) stock crashed 57% on Wednesday, September 30, after a Delaware court ruled that Yutrepia infringes two valid claims of United Therapeutics’ ‘327 patent. Those claims cover treating pulmonary hypertension with interstitial lung disease (PH-ILD) using inhaled treprostinil, and the court struck down the rest.

Yahoo10/1/2026

United Therapeutics Soars 13% as Court Rules Yutrepia Infringes Its Patent

United Therapeutics Corporation (UTHR:NASDAQ) shares jumped about 13% on Wednesday, September 30 (closing at $542), after a federal court ruled that rival Liquidia’s lung drug infringes its treprostinil patent. Liquidia (LQDA:NASDAQ) fell nearly 50% on the same ruling, wiping out about $3.

Yahoo10/1/2026

Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) jumped 13.6% in the afternoon session after a federal district court ruled that competitor Liquidia Corporation infringed patent claims covering United Therapeutics' inhaled treprostinil treatments.

Yahoo9/30/2026

Why is Liquidia (LQDA) Stock Trending After Hours?

Liquidia Corp. shares gained 0.13% after hours after closing 57.19% lower following an adverse patent ruling.

Benzinga9/30/2026

United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., September 30, 2026--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the United States District Court for the District of Delaware issued an opinion that finds Liquidia Technologies, Inc. (Liquidia) infringes two claims of United Therapeutics’ patent covering the use of inhaled treprostinil to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Yahoo9/30/2026

Stock Market Today: Dow Wavers Ahead Of Key Inflation Data; Micron Report Due (Live Coverage)

The Dow Jones index wavers Wednesday ahead of key inflation data. Micron earnings are due after the close.

Yahoo9/30/2026

United Just Pulled The Ultimate Bull Move, As Its Chief Rival Collapsed

A district judge ruled Wednesday that Liquidia infringed on United Therapeutics' patents with its drug, Yutrepia. The stocks diverged.

Yahoo9/30/2026

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks declined late Wednesday afternoon with the NYSE Healthcare Index and the State Str

Yahoo9/30/2026

LQDA Stock Eyes Worst Day Ever After Judge Upholds Two UTHR Patent Claims

Liquidia CEO Roger Jeffs said the company disagrees with the court’s decision and will “pursue all available appellate options.”

Yahoo9/30/2026

Stock Market Today: Nasdaq Leads Rise; AI Giant Microsoft Tests A New Entry (Live Coverage)

Stock Market Today: The Dow Jones index rises Wednesday on surprise inflation data. Micron earnings are due after the close.

Yahoo9/30/2026

Top movers analysis one hour before the close of the markets on 2026-09-30: top gainers and losers in today's session.

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

ChartMill9/30/2026

Liquidia shares crater after court rules for United Therapeutics

Investing.com -- Liquidia Corp shares fell Wednesday after a U.S. District Court in Delaware ruled the company infringed two patent claims held by United Therapeutics Corp. United Therapeutics shares rose more than 13%.

Yahoo9/30/2026

Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent

District Court ruled that two of the six claims asserted against Liquidia are valid and infringedParties directed to submit form of judgment, specifying the proposed remedy, for the District Court’s consideration within one week MORRISVILLE, N.C., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today issued an update regarding

Yahoo9/30/2026

LQDA versus ALKS: Which Biotech Stock Is the Better Buy Now?

LQDA's Yutrepia drives rapid growth, while ALKS benefits from a diversified portfolio, Lumryz and a broader pipeline.

Yahoo9/30/2026

Let's take a look at the stocks that are in motion in today's session.

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

ChartMill9/30/2026

Liquidia: Bullish On Their Growth Potential Despite YUTREPIA's Legal Tail Risk

YUTREPIA’s adoption is translating into profits and cash, giving Liquidia an operating foundation for further growth. Click for more on LQDA.

SeekingAlpha9/30/2026

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 147.1% to $0.18 during Wednesday's regular session. Tenon Medical (NASDAQ:TNON) stock increased by 47.25% to $4.02. The market value of their

Benzinga9/30/2026

Judge Upholds Claims 1 And 14 Of United Therapeutics' '327 Patent, Rules Liquidia Infringes; Final Judgment Due Within One Week

https://storage.courtlistener.com/recap/gov.uscourts.ded.83482/gov.uscourts.ded.83482.475.0_1.pdf

Benzinga9/30/2026

Liquidia (NASDAQ:LQDA) High Growth Momentum Meets a Pre-Breakout Setup

Liquidia Corp scores 8 for growth momentum plus strong technical and setup ratings, flagging a pre-breakout biopharma stock with rapid EPS and revenue growth.

ChartMill9/30/2026

Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday

U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial results; several small caps also rallied.

Benzinga9/28/2026

United Therapeutics: The Market Sees The Erosion, Not The Refill - Buy

United Therapeutics' declines are real but they sit in ~32% of the business, tax-normalized earnings power is $1.05 billion. See why UTHR stock is a Buy now.

SeekingAlpha9/27/2026

10 Health Care Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

Benzinga9/24/2026

Can LQDA's Yutrepia Outpace Intensifying PAH Competition?

Liquidia's Yutrepia posts rapid sales growth, but intensifying competition from established therapies and emerging drugs could test its momentum.

Yahoo9/23/2026

Liquidia (NASDAQ:LQDA): Strong Growth Paired With Technical Setup Quality

Liquidia (LQDA) pairs strong growth with a technical consolidation setup above defined support; watch resistance for a potential volume breakout.

ChartMill9/19/2026

LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?

Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.

Yahoo9/11/2026

Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio?

Liquidia's Yutrepia wins FDA Fast Track status for SSc-related Raynaud's, opening a potential new growth avenue for the lead drug.

Yahoo9/10/2026

LIQUIDIA CORP (NASDAQ:LQDA) Fits the Affordable Growth Screen

LQDA: Affordable growth biopharma stock focused on rare cardiopulmonary diseases, with strong revenue growth and reasonable forward valuation.

ChartMill9/9/2026

Does FDA Fast Track For YUTREPIA In SSc Raynaud’s Change The Bull Case For Liquidia (LQDA)?

Liquidia Corporation recently reported that the U.S. Food and Drug Administration granted Fast Track designation to YUTREPIA (treprostinil) inhalation powder for treating Raynaud's phenomenon associated with systemic sclerosis, and the company expects to begin its Phase 2a RE-WARM dose-finding study in October 2026. This designation highlights a potential new use for an existing pulmonary arterial hypertension therapy in an area where no approved U.S. treatments currently exist, underscoring...

Yahoo9/5/2026

Is Liquidia (LQDA) Still Undervalued As Fast Track News Tests Its Valuation?

The U.S. Food and Drug Administration has granted Fast Track designation to Liquidia (LQDA) therapy YUTREPIA for Raynaud's phenomenon in systemic sclerosis, drawing investor attention to the stock and its rare disease pipeline. Liquidia’s latest Fast Track news lands after a sharp pullback, with the share price down about 22% over the past month and slightly weaker over the last week, even though the year to date share price return is 118.57% and the 1 year total shareholder return is...

Yahoo9/4/2026

Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks

Liquidia stock has delivered very strong long term gains over the past five years, yet current valuation checks present a more cautious picture that investors need to weigh carefully. After such a large move in the share price, the key issue is whether the recent performance and expectations around its pipeline are already fully reflected in what the market is paying today. Over the past five years, Liquidia has returned about 24x. This places a lot of weight on the company continuing to...

Yahoo9/4/2026

Related Stocks (Peers)

Companies operating in similar sectors to LQDA:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-14SINGH RAMAN-8,468--
2026-09-14SINGH RAMAN-8,468$66.16$560,243
2026-09-14SINGH RAMAN+8,468$9.3055$78,799
2026-09-11SINGH RAMAN-8,468--
2026-09-11SINGH RAMAN-556--
2026-09-11SINGH RAMAN-9,024$68.6181$619,210
2026-09-11SINGH RAMAN+8,468$9.3055$78,799
2026-09-11SINGH RAMAN+556$8.63$4,798
2026-09-01Krepp Sarah-274$67.7603$18,566
2026-08-21Adair Jason-238--
2026-08-21Adair Jason-10,762--
2026-08-21Adair Jason-11,799--
2026-08-21Adair Jason-9,000--
2026-08-21Adair Jason-41,832$69.0908$2,890,206
2026-08-21Adair Jason-31,799$69.0908$2,197,018
2026-08-21Adair Jason+238$14.2$3,380
2026-08-21Adair Jason+10,762$14.2$152,820
2026-08-21Adair Jason+11,799$9.31$109,849
2026-08-21Adair Jason+9,000$9.31$83,790
2026-08-20Rielly-Gauvin Katherine-6,666--
2026-08-20Rielly-Gauvin Katherine-11,727--
2026-08-20Rielly-Gauvin Katherine-18,393$72.2273$1,328,477
2026-08-20Rielly-Gauvin Katherine+6,666$2.59$17,265
2026-08-20Rielly-Gauvin Katherine+11,727$2.51$29,435
2026-08-19Saggar Rajeev-50,000--
2026-08-19Saggar Rajeev-50,000$74.0565$3,702,825
2026-08-19Saggar Rajeev+50,000$3.73$186,500
2026-08-19Rielly-Gauvin Katherine-13,334--
2026-08-19Rielly-Gauvin Katherine-23,455--
2026-08-19Rielly-Gauvin Katherine-36,789$74.9941$2,758,958
2026-08-19Rielly-Gauvin Katherine+13,334$2.59$34,535
2026-08-19Rielly-Gauvin Katherine+23,455$2.51$58,872
2026-08-17Saggar Rajeev-29,534$76.8396$2,269,381
2026-07-27Boyle Dana-1,600$87.53$140,048
2026-07-27Adair Jason-688$87.53$60,221
2026-07-23Bloch Stephen M-3,600$90.7065$326,543
2026-07-23Bloch Stephen M-96,400$89.4388$8,621,900
2026-07-22Bloch Stephen M-14,562$89.2425$1,299,549
2026-07-22Bloch Stephen M-48,032$88.6461$4,257,849
2026-07-22Bloch Stephen M-37,406$87.7016$3,280,566
2026-07-21Bloch Stephen M-556$80.6576$44,846
2026-07-21Bloch Stephen M-74,444$79.9841$5,954,336
2026-07-20Bloch Stephen M-3,596$79.5518$286,068
2026-07-13Krepp Sarah-7,306$71.52$522,525
2026-07-13Krepp Sarah-558$71.39$39,836
2026-07-13Khindri Sanjeev-1,101$71.52$78,744
2026-07-13Khindri Sanjeev-84$71.39$5,997
2026-07-13Schundler Russell-13,692$71.52$979,252
2026-07-13Schundler Russell-1,046$71.39$74,674
2026-07-13Saggar Rajeev-9,223$71.52$659,629
2026-07-13Saggar Rajeev-703$71.39$50,187
2026-07-13Moomaw Scott-8,864$71.52$633,953
2026-07-13Moomaw Scott-675$71.39$48,188
2026-07-13Boyle Dana-8,361$71.52$597,979
2026-07-13Boyle Dana-641$71.39$45,761
2026-07-13Adair Jason-7,301$71.52$522,168
2026-07-13Adair Jason-562$71.39$40,121
2026-07-13Kaseta Michael-18,977$71.52$1,357,235
2026-07-13Kaseta Michael-1,453$71.39$103,730
2026-07-13JEFFS ROGER-32,744$71.52$2,341,851
2026-07-13JEFFS ROGER-2,505$71.39$178,832
2026-07-10Krepp Sarah-3,179--
2026-07-10Krepp Sarah+3,179--
2026-07-10Schundler Russell-6,409--
2026-07-10Schundler Russell-3,759--
2026-07-10Schundler Russell+6,409--
2026-07-10Schundler Russell+3,759--
2026-07-10Saggar Rajeev-4,487--
2026-07-10Saggar Rajeev-3,531--
2026-07-10Saggar Rajeev+4,487--
2026-07-10Saggar Rajeev+3,531--
2026-07-10Moomaw Scott-4,358--
2026-07-10Moomaw Scott-3,108--
2026-07-10Moomaw Scott+4,358--
2026-07-10Moomaw Scott+3,108--
2026-07-10Boyle Dana-3,179--
2026-07-10Boyle Dana+3,179--
2026-07-10Adair Jason-3,869--
2026-07-10Adair Jason-2,475--
2026-07-10Adair Jason-3,907--
2026-07-10Adair Jason+3,869--
2026-07-10Adair Jason+2,475--
2026-07-10Adair Jason+3,907--
2026-07-10Kaseta Michael-7,050--
2026-07-10Kaseta Michael-5,829--
2026-07-10Kaseta Michael+7,050--
2026-07-10Kaseta Michael+5,829--
2026-07-10JEFFS ROGER-14,333--
2026-07-10JEFFS ROGER-13,834--
2026-07-10JEFFS ROGER+14,333--
2026-07-10JEFFS ROGER+13,834--
2026-07-07Bloch Stephen M-27,282$81.3128$2,218,376
2026-07-07Bloch Stephen M-22,718$80.4833$1,828,420
2026-07-06Bloch Stephen M-25,000$80.175$2,004,375
2026-07-01Bloch Stephen M-853$80.045$68,278
2026-07-01Bloch Stephen M-24,147$79.4474$1,918,416
2026-06-22Bloch Stephen M-30,500$76.1776$2,323,417
2026-06-22Bloch Stephen M-69,500$75.5437$5,250,287
2026-06-16Horobin Joanna+5,882--
2026-06-16Manning Paul B+5,882--
2026-06-16Bloch Stephen M+5,882--
2026-06-16KIRSCH ARTHUR S+5,882--
2026-06-15Bloch Stephen M-2,322$72.0762$167,361
2026-06-15Bloch Stephen M-82,740$71.418$5,909,125
2026-06-12Bloch Stephen M-13,095$72.1544$944,862
2026-06-12Bloch Stephen M-97,954$71.3726$6,991,232
2026-06-11Krepp Sarah-19,131$70.2784$1,344,496
2026-06-11Krepp Sarah-5,749$70.2784$404,031
2026-06-11Bloch Stephen M-686$72.4095$49,673
2026-06-11Bloch Stephen M-92,128$71.7405$6,609,309
2026-06-11Bloch Stephen M-20,208$71.0671$1,436,124
2026-06-11Bloch Stephen M-85,285$69.874$5,959,204
2026-06-11Bloch Stephen M-25,117$68.9063$1,730,720
2026-06-11Bloch Stephen M-17,369$67.9034$1,179,414
2026-06-11Bloch Stephen M-1,476$66.3959$98,000
2026-06-10Bloch Stephen M-28,237$66.3033$1,872,206
2026-06-10Bloch Stephen M-103,301$65.5423$6,770,585
2026-06-10Bloch Stephen M-14,416$64.4807$929,554
2026-06-09Bloch Stephen M-8,034$65.243$524,162
2026-06-09Bloch Stephen M-64,500$64.2718$4,145,531
2026-06-08Khindri Sanjeev-4,134$65.46$270,612
2026-06-08Bloch Stephen M-2,804$66.188$185,591
2026-06-08Bloch Stephen M-39,187$65.3796$2,562,030
2026-06-08Bloch Stephen M-106,310$64.4941$6,856,368
2026-06-05Bloch Stephen M-2,064$64.1394$132,384
2026-06-04Manning Paul B-12,610$64.42$812,336
2026-06-04Manning Paul B-68,265$63.83$4,357,355
2026-06-04Manning Paul B-19,125$62.62$1,197,608
2026-06-04Manning Paul B-88,487$64.28$5,687,944
2026-06-04Manning Paul B-11,513$63.13$726,816
2026-06-04Bloch Stephen M-1,420$66.0786$93,832
2026-06-04Bloch Stephen M-35,208$65.5824$2,309,025
2026-06-04Bloch Stephen M-46,108$64.4691$2,972,541
2026-06-03KIRSCH ARTHUR S-10,000$54.8$548,000
2026-06-02KIRSCH ARTHUR S-5,000$56$280,000
2026-06-01Krepp Sarah-276$60.87$16,800
2026-06-01KIRSCH ARTHUR S-15,000$60.22$903,300
2026-05-27JEFFS ROGER-6,428$62.183$399,712
2026-05-26JEFFS ROGER-25,000$60.3784$1,509,460
2026-05-22JEFFS ROGER-25,000$61.5222$1,538,055
2026-05-21SINGH RAMAN-10,050--
2026-05-21SINGH RAMAN-19,444--
2026-05-21SINGH RAMAN-29,494$60.1287$1,773,436
2026-05-21SINGH RAMAN+10,050$11$110,550
2026-05-21SINGH RAMAN+19,444$8.63$167,802
2026-05-21JEFFS ROGER-25,000$61.1264$1,528,160
2026-05-20JEFFS ROGER-25,000$61.3019$1,532,548
2026-05-19Caligan Partners LP+5,300$59.98$317,894
2026-05-19Caligan Partners LP-5,300$59.98$317,894
2026-05-19JEFFS ROGER-25,000$58.6457$1,466,143
2026-05-18JEFFS ROGER-25,000$56.7728$1,419,320
2026-05-15JEFFS ROGER-25,000$57.0429$1,426,073
2026-05-14JEFFS ROGER-25,000$58.6226$1,465,565
2026-05-13JEFFS ROGER-25,000$56.2851$1,407,128
2026-05-12JEFFS ROGER-25,000$54.0396$1,350,990
2026-05-11Bloch Stephen M-14,207$53.253$756,565
2026-05-11Bloch Stephen M-75,293$52.3759$3,943,539
2026-05-11Bloch Stephen M-10,500$51.3107$538,762
2026-05-11Bloch Stephen M-27,613$50.1029$1,383,491
2026-05-11Bloch Stephen M-115,479$49.4452$5,709,882
2026-05-11Bloch Stephen M-75,801$48.608$3,684,535
2026-05-11JEFFS ROGER-25,000$41.4961$1,037,403
2026-05-08JEFFS ROGER-25,000$42.1426$1,053,565
2026-05-07JEFFS ROGER-25,000$42.0854$1,052,135
2026-05-06JEFFS ROGER-25,000$40.7829$1,019,573
2026-05-05JEFFS ROGER-25,000$40.1037$1,002,593
2026-04-27Boyle Dana-1,576$37.78$59,541
2026-04-27Adair Jason-688$41.65$28,655
2026-04-17JEFFS ROGER-18,839$40.6049$764,956
2026-04-16JEFFS ROGER-25,000$40.312$1,007,800
2026-04-15Kaseta Michael-86,971--
2026-04-15Kaseta Michael-43,375$40.1409$1,741,112
2026-04-15Kaseta Michael-86,971$40.1409$3,491,094
2026-04-15Kaseta Michael+86,971$2.79$242,649
2026-04-15Kaseta Michael-9,044$40.1409$363,034
2026-04-15JEFFS ROGER-25,000$40.1409$1,003,523
2026-04-14Kaseta Michael-3,000--
2026-04-14Kaseta Michael-3,000$40$120,000
2026-04-14Kaseta Michael+3,000$2.79$8,370
2026-04-14JEFFS ROGER-3,300$40$132,000
2026-04-13Moomaw Scott-1,686$38.2$64,405
2026-04-13Moomaw Scott-8,861$38.37$339,997
2026-04-13Boyle Dana-5,101$38.37$195,725
2026-04-13Krepp Sarah-4,557$38.37$174,852
2026-04-13Saggar Rajeev-9,220$38.37$353,771
2026-04-13Schundler Russell-13,692$38.37$525,362
2026-04-13Adair Jason-7,301$38.37$280,139
2026-04-13Kaseta Michael-18,958$38.37$727,418
2026-04-13JEFFS ROGER-32,744$38.37$1,256,387
2026-04-10Moomaw Scott-4,358--
2026-04-10Moomaw Scott-3,107--
2026-04-10Moomaw Scott+4,358--
2026-04-10Moomaw Scott+3,107--
2026-04-10Boyle Dana-3,179--
2026-04-10Boyle Dana+3,179--
2026-04-10Krepp Sarah-3,179--
2026-04-10Krepp Sarah+3,179--
2026-04-10Saggar Rajeev-4,486--
2026-04-10Saggar Rajeev-3,531--
2026-04-10Saggar Rajeev+4,486--
2026-04-10Saggar Rajeev+3,531--
2026-04-10Schundler Russell-6,409--
2026-04-10Schundler Russell-3,758--
2026-04-10Schundler Russell+6,409--
2026-04-10Schundler Russell+3,758--
2026-04-10Adair Jason-3,868--
2026-04-10Adair Jason-2,474--
2026-04-10Adair Jason-3,906--
2026-04-10Adair Jason+3,868--
2026-04-10Adair Jason+2,474--
2026-04-10Adair Jason+3,906--
2026-04-10Kaseta Michael-7,050--
2026-04-10Kaseta Michael-5,828--
2026-04-10Kaseta Michael-23,821--
2026-04-10Kaseta Michael+7,050--
2026-04-10Kaseta Michael+5,828--
2026-04-10Kaseta Michael-23,821$40.1431$956,249
2026-04-10Kaseta Michael+23,821$2.79$66,461
2026-04-10JEFFS ROGER-14,333--
2026-04-10JEFFS ROGER-13,834--
2026-04-10JEFFS ROGER-21,433$40.1193$859,877
2026-04-10JEFFS ROGER+14,333--
2026-04-10JEFFS ROGER+13,834--
2026-04-09Kaseta Michael-9,272--
2026-04-09Kaseta Michael-728--
2026-04-09Kaseta Michael-18,115--
2026-04-09Kaseta Michael-86,632--
2026-04-09Kaseta Michael-19,042--
2026-04-09Kaseta Michael-133,789$40.2379$5,383,388
2026-04-09Kaseta Michael+9,272$2.54$23,551
2026-04-09Kaseta Michael+728$2.54$1,849
2026-04-09Kaseta Michael+18,115$2.97$53,802
2026-04-09Kaseta Michael+86,632$2.79$241,703
2026-04-09Kaseta Michael+19,042$2.79$53,127
2026-04-09JEFFS ROGER-25,000$40.1155$1,002,887
2026-03-27Bloch Stephen M-1,973$37.1303$73,258
2026-03-27Bloch Stephen M-30,176$36.3758$1,097,676
2026-03-27Bloch Stephen M-30,401$35.4214$1,076,846
2026-03-26Bloch Stephen M-7,684$37.2183$285,985
2026-03-23Moomaw Scott-17,000--
2026-03-23Moomaw Scott-17,000$36.8128$625,818
2026-03-23Moomaw Scott+17,000$3.4$57,800
2026-03-23Moomaw Scott-1,314$36.48$47,935
2026-03-13Saggar Rajeev-35,365$36.3024$1,283,834
2026-03-13Krepp Sarah-16,261$38$617,918
2026-03-13SINGH RAMAN-20,000--
2026-03-13SINGH RAMAN-20,000$36.0414$720,828
2026-03-13SINGH RAMAN+20,000$4.86$97,200
2026-03-09Moomaw Scott-54,700--
2026-03-09Moomaw Scott-15,300--
2026-03-09Moomaw Scott-10,000--
2026-03-09Moomaw Scott-80,000$35.3228$2,825,824
2026-03-09Moomaw Scott+54,700$3.4$185,980
2026-03-09Moomaw Scott+15,300$2.97$45,441
2026-03-09Moomaw Scott+10,000$2.54$25,400
2026-03-02Moomaw Scott-827$30.58$25,290
2026-03-02Boyle Dana-445$30.58$13,608
2026-03-02Adair Jason-689$30.58$21,070
2026-03-02Schundler Russell-1,073$30.58$32,812
2026-03-02Krepp Sarah-276$30.58$8,440
2026-03-02Kaseta Michael-1,165$30.58$35,626
2026-02-27Moomaw Scott-1,875--
2026-02-27Moomaw Scott+1,875--
2026-02-27Adair Jason-1,562--
2026-02-27Adair Jason+1,562--
2026-02-27Schundler Russell-2,344--
2026-02-27Schundler Russell+2,344--
2026-02-27Kaseta Michael-2,344--
2026-02-27Kaseta Michael+2,344--
2026-02-11Manning Paul B+55,116$42.63$2,349,595
2026-02-11Manning Paul B-55,116$42.63$2,349,595
2026-01-26Boyle Dana-1,580$41.65$65,807
2026-01-26Adair Jason-688$41.65$28,655
2026-01-16Boyle Dana+35,592--
2026-01-16Boyle Dana+23,728--
2026-01-16Khindri Sanjeev+34,274--
2026-01-16Krepp Sarah+35,592--
2026-01-16Krepp Sarah+23,728--
2026-01-16Moomaw Scott+49,433--
2026-01-16Moomaw Scott+32,955--
2026-01-16Saggar Rajeev+49,433--
2026-01-16Saggar Rajeev+32,955--
2026-01-16Schundler Russell+49,433--
2026-01-16Schundler Russell+32,955--
2026-01-16Adair Jason+41,525--
2026-01-16Adair Jason+27,683--
2026-01-16Kaseta Michael+88,980--
2026-01-16Kaseta Michael+59,320--
2026-01-16JEFFS ROGER+173,016--
2026-01-16JEFFS ROGER+115,344--
2026-01-12Krepp Sarah-13,165$37.43$492,766
2026-01-12Moomaw Scott-20,533$37.43$768,550
2026-01-12Schundler Russell-27,289$37.43$1,021,427
2026-01-12Boyle Dana-11,047$37.43$413,489
2026-01-12Saggar Rajeev-21,142$37.43$791,345
2026-01-12Adair Jason-13,548$37.43$507,102
2026-01-12Kaseta Michael-36,932$37.43$1,382,365
2026-01-12JEFFS ROGER-66,610$37.43$2,493,212
2026-01-09Krepp Sarah-12,716--
2026-01-09Krepp Sarah+12,716--
2026-01-09Moomaw Scott-17,433--
2026-01-09Moomaw Scott-3,108--
2026-01-09Moomaw Scott+17,433--
2026-01-09Moomaw Scott+3,108--
2026-01-09Schundler Russell-25,636--
2026-01-09Schundler Russell-3,759--
2026-01-09Schundler Russell+25,636--
2026-01-09Schundler Russell+3,759--
2026-01-09Boyle Dana-12,716--
2026-01-09Boyle Dana+12,716--
2026-01-09Saggar Rajeev-17,945--
2026-01-09Saggar Rajeev-3,531--
2026-01-09Saggar Rajeev+17,945--
2026-01-09Saggar Rajeev+3,531--
2026-01-09Adair Jason-15,474--
2026-01-09Adair Jason-2,474--
2026-01-09Adair Jason+15,474--
2026-01-09Adair Jason+2,474--
2026-01-09Adair Jason+3,906--
2026-01-09Kaseta Michael-28,200--
2026-01-09Kaseta Michael-5,828--
2026-01-09Kaseta Michael+28,200--
2026-01-09Kaseta Michael+5,828--
2026-01-09JEFFS ROGER-57,332--
2026-01-09JEFFS ROGER-13,833--
2026-01-09JEFFS ROGER+57,332--
2026-01-09JEFFS ROGER+13,833--
2025-12-01Schundler Russell-1,072$32.19$34,508
2025-12-01Krepp Sarah-221$32.19$7,114
2025-12-01Boyle Dana-303$32.19$9,754
2025-12-01Moomaw Scott-831$32.19$26,750
2025-12-01Adair Jason-693$32.19$22,308
2025-12-01Kaseta Michael-1,166$32.19$37,534
2025-11-28Schundler Russell-2,343--
2025-11-28Schundler Russell+2,343--
2025-11-28Moomaw Scott-1,875--
2025-11-28Moomaw Scott+1,875--
2025-11-28Adair Jason-1,563--
2025-11-28Adair Jason+1,563--
2025-11-28Kaseta Michael-2,343--
2025-11-28Kaseta Michael+2,343--
2025-11-18Adair Jason-365--
2025-11-18Adair Jason-35,291--
2025-11-18Adair Jason-35,656$30.0289$1,070,710
2025-11-18Adair Jason+365$5.89$2,150
2025-11-18Adair Jason+35,291$5.89$207,864
2025-11-07Boyle Dana-20,662$25.06$517,790
2025-11-07Boyle Dana-8,342$25.16$209,885
2025-11-05Saggar Rajeev-66,463$27$1,794,501
2025-11-05Saggar Rajeev-4,918$27$132,786
2025-10-27Boyle Dana-1,073$22.93$24,604
2025-10-27Adair Jason-692$22.93$15,868
2025-10-13Schundler Russell-7,839$23.41$183,511
2025-10-13Moomaw Scott-4,900$23.41$114,709
2025-10-13Saggar Rajeev-5,327$23.41$124,705
2025-10-13Boyle Dana-1,238$23.41$28,982
2025-10-13Krepp Sarah-1,691$23.41$39,586
2025-10-13Adair Jason-3,670$23.41$85,915
2025-10-13Kaseta Michael-11,630$23.41$272,258
2025-10-13JEFFS ROGER-20,261$23.41$474,310
2025-10-10Schundler Russell-3,758--
2025-10-10Schundler Russell+3,758--
2025-10-10Moomaw Scott-3,108--
2025-10-10Moomaw Scott+3,108--
2025-10-10Saggar Rajeev-3,530--
2025-10-10Saggar Rajeev+3,530--
2025-10-10Adair Jason-2,474--
2025-10-10Adair Jason-3,906--
2025-10-10Adair Jason+2,474--
2025-10-10Adair Jason+3,906--
2025-10-10Kaseta Michael-5,828--
2025-10-10Kaseta Michael+5,828--
2025-10-10JEFFS ROGER-13,834--
2025-10-10JEFFS ROGER+13,834--